Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.

Autor/a

Carbó, Neus

López-Soriano, Francisco J.

Tarragó, Teresa

González, Olga

Llovera i Tomàs, Marta

López-Soriano, Joaquín

Argilés, Josep M.

Data de publicació

2016-05-05T07:39:46Z

2025-01-01

1997



Resum

The implantation of the Yoshida AH- 130 ascites hepatoma (a fast growing tumour) to rats resulted in a drarnatic loss of both white adipose tissue and muscle (skeletal and cardiac) mass. Administration of &adrenergic agonists to rumour-hearing rats resulted in a partial recovery of skeletal muscle and heart mass. Treatment of the tumour-bearing animals with the different drugs (salbutamol, salmeterol and clenbuterol) did not influence tumour growth or food intake so it can be suggested that the effects were solely due to metabolic changes. In addition, while the three drugs had clear effects on gastrocnemius muscles, clenbuterol and salbutamol had also an effect on soleus, and salbutamol had a clear effect on cardiac muscle. It is suggested that any of the studied &adrenergic agonists (but perhaps, particularly salmeterol) could be used clinicany in the treatment of cancer cachexia.

Tipus de document

article
publishedVersion

Llengua

Anglès

Matèries i paraules clau

Tumour growth; Muscle waste; β2 agonists

Publicat per

Elsevier

Documents relacionats

Reproducció del document publicat a https://doi.org/10.1016/S0304-3835(97)04718-6

Cancer Letters, 1997, vol. 115, núm. 1, p. 113-118

Drets

(c) Elsevier Science Ireland Ltd., 1997

Aquest element apareix en la col·lecció o col·leccions següent(s)